EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
2 clinical trials · Condition
◉ Watch EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS (NCT06925555) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients (NCT05577364) | Sun Yat-sen University | 2022-11-01 |
Track EBV-Positive Diffuse Large B-Cell Lymphoma, Nos automatically
Every clearance here is in the API, with alerts when new ones post.